Yong Ma

ORCID: 0000-0003-2033-6890

Also affiliated with Shanxi Provincial Cancer Hospital, Group W (United States)

Biochemistry, Genetics and Molecular BiologyAgricultural and Biological SciencesPharmacology, Toxicology and PharmaceuticsMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

1in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Papers

Driven by 2 papers. Top paper: “A new method for primary culture of microglia in rats with spinal cord injury”.

A new method for primary culture of microglia in rats with spinal cord injury

Biochemical and Biophysical Research Communications(2022)10.1016/j.bbrc.2022.02.027

N/A

0.231DataRank · unranked

2 citations

Yalan Pan, Lining Wang, Mengmin Liu, Mao Wu, Jianwei Wang +4 more

Leveraging Case Narratives to Enhance Patient Age Ascertainment from Adverse Event Reports

Pharmaceutical Medicine(2021)10.1007/s40290-021-00398-5

N/A

0DataRank · unranked

9 citations

Carmen Cheng, Eileen Wu, Ivone Kim, Rongmei Zhang, Yong Ma +3 more